Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$355,956
+$67,052 QoQ
Shares Held
2,112
-3.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#517
of 767 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BOKF, NA holds $12,347,827 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
6,977 | $3,780,347 | |
| 2 | VTRS |
Viatris Inc
|
222,511 | $3,533,474 | |
| 3 | ZTS |
Zoetis Inc.
|
37,061 | $2,663,202 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
14,295 | $517,479 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
4,610 | $511,433 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
6,015 | $497,921 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
10,324 | $488,015 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,112 | $355,956 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $355,956 | 2,112 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $288,904 | 2,193 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $307,203 | 2,166 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $364,987 | 2,600 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $328,427 | 2,613 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $698,881 | 6,319 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $550,368 | 4,032 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $463,068 | 4,019 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $551,781 | 4,008 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $555,954 | 4,031 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $527,830 | 4,006 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $447,637 | 3,979 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $418,503 | 4,438 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $474,721 | 4,690 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $604,007 | 5,057 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $509,064 | 4,793 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $474,629 | 4,869 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $449,812 | 4,798 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $395,273 | 4,641 | Shares | Other | 2022-03-11 | |
| 2021-09-30 | $526,737 | 5,492 | Shares | Other | 2021-11-10 | |
| 2021-03-31 | $1,965,228 | 20,208 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $1,810,222 | 18,886 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $1,916,179 | 19,927 | Shares | Other | 2020-10-30 | |
| 2020-06-30 | $2,311,778 | 18,949 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $1,726,066 | 19,943 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||